Verastem (VSTM) Revenue (2018 - 2026)

Verastem (VSTM) recorded quarterly Revenue of $18.7 million in Q1 2026, up 6.48% quarter-over-quarter from $17.5 million in Q4 2025.

Verastem (VSTM) Revenue (2018 - 2026) Analysis & Trends

Verastem's Revenue history runs 8 years deep, the most recent figure standing at $18.7 million for Q1 2026.

  • In Q1 2026, Revenue changed N/A year-over-year to $18.7 million; the TTM figure through Mar 2026 stood at $49.6 million (changed N/A YoY), while the FY2025 annual figure was $30.9 million, up 209.14% from the prior year.
  • Revenue was $18.7 million for Q1 2026 at Verastem, up from $17.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $18.7 million in Q1 2026 to a low of $2.1 million in Q2 2025.
  • Historically, Revenue has averaged $10.4 million across 4 years, with a median of $10.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Revenue soared 158.05% in 2022, then plunged 78.63% in 2025.
  • A 4-year view of Revenue shows it stood at $2.6 million in 2022, then jumped by 285.21% to $10.0 million in 2024, then soared by 75.35% to $17.5 million in 2025, then increased by 6.48% to $18.7 million in 2026.
  • The last three Revenue figures came in at $18.7 million (Q1 2026), $17.5 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 18.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.67 Mn
Dec 31, 2025 17.54 Mn
Sep 30, 2025 11.24 Mn
Jun 30, 2025 2.14 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2022 2.60 Mn
Dec 31, 2021 545,000.00
Sep 30, 2021 2,000.00
Jun 30, 2021 500,000.00
Mar 31, 2021 1.01 Mn
Dec 31, 2020 506,000.00
Sep 30, 2020 78.65 Mn
Jun 30, 2020 4.31 Mn
Mar 31, 2020 5.06 Mn
Dec 31, 2019 3.62 Mn
Sep 30, 2019 9.03 Mn
Jun 30, 2019 3.14 Mn
Mar 31, 2019 1.67 Mn
Dec 31, 2018 1.21 Mn
Sep 30, 2018 15.51 Mn